Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.

Borja RuizUrko AguirreAna Estany-GestalLuca RodellaPablo RuizAdolfo FigueirasAlfonso CarvajalLuisa IbáñezAnita ConfortiMarian M de PancorboXavier VidalLuis H MartinCarmelo Aguirre

Published in: European journal of clinical pharmacology (2018)

These results reinforce the recommendation of adding a PPI at effective doses (full adherence) to prevent UGIB induced by NSAIDs, or single- or dual-antiplatelet therapy.

Keyphrases

drug induced
antiplatelet therapy
liver injury
acute coronary syndrome
percutaneous coronary intervention
glycemic control
adverse drug
coronary artery disease
type diabetes
skeletal muscle
adipose tissue
weight loss